Technologies by Gabriel Kwong
Antigen-specific Cell Programming Using non-viral Approaches
T cell therapies can be costly and carry serious risks
8703
Scarless isolation of antigen-specific T cells for CAR T cell manufacturing via DNA-gated sorting
CAR T cell therapies are often limited in effectiveness against solid tumors
9388
Activity-based synthetic liquid biopsy of solid tumors
Methods for monitoring tumors can be invasive and ineffective
9387
Engineering Antigen-Specific T Cells for CAR T Cell Therapy via Antigen-Presenting Lipid Nanoparticles
Production costs and complexities limit efficiency
9386
A Biological Computing Framework for Living Systems
Providing a foundation for programmable medicine
Providing a foundation for programmable medicine
8009
Heat-Responsive Programmable T-Cells
Increasing oncological patients’ precision medicine with engineered T-cell therapies that contain heat-responsive biocircuitry
Increasing oncological patients’ precision medicine with engineered T-cell therapies that contain heat-responsive biocircuitry
7422
Self-Titrating Bacterial Protease-Activated Prodrug
A new strategy to reduce antibiotic-resistant bacteria
A new strategy to reduce antibiotic-resistant bacteria
8010